Diabetes management app development is the process of designing, building, and validating a mobile app that helps people with diabetes track glucose, medication, food, and activity, and share that data with their care team. For medical device companies, it also means deciding early whether the app is a regulated device, because that decision shapes the architecture, documentation, and testing for the whole project.
This guide walks through that process in order: understanding your users, choosing core features, connecting to CGMs and other devices, applying FDA rules where they fit, and testing with real users. It is written for teams building an app that sits alongside a glucose sensor, insulin pump, or other diabetes device.
Start with your users
Before you sketch a single screen, you need to know who will use the app, what gets in their way today, and what their care team needs from it. Those answers decide which features matter, how the interface should behave, and what you will test later.
Who will use the app?
Age, cultural background, and socioeconomic status all shape what users need, what they prefer, and how comfortable they are with technology. A newly diagnosed teenager, a parent managing a child’s type 1 diabetes, and an older adult with type 2 diabetes will use the same app in very different ways.
Gather this picture through surveys, user interviews, data analytics, and market research. Use what you learn to shape the interface and feature set so the app fits the people it serves. A clear view of your user base also helps you design for groups that current tools underserve.
What gets in their way?
Look beyond the daily work of living with diabetes to the pain points people have with the technology they already use. In-depth interviews with patients and healthcare professionals are often the most revealing method here.
Common challenges include:
- Managing medication and insulin doses
- Monitoring blood glucose and making sense of the numbers
- Following dietary guidance day to day
- Coping with the psychological stress of constant self-management
Each challenge points to a feature that can make self-management easier, as long as it is designed around how people actually live.
What do clinicians need from it?
Clinicians bring medical and behavioral insight, and they often see problems patients do not raise or cannot put into words. Work with them through interviews, focus groups, or an advisory panel that includes endocrinologists, diabetes educators, nurses, parents, and other experts.
Clinicians can explain the guidelines and treatment protocols the app must respect. They can also review features, interfaces, and analytics, and confirm that the app fits medical standards and the workflows they already use.
Record these findings as user needs. They become the basis for your requirements and for usability testing later. For a deeper walkthrough, see our guide to defining user needs for diabetes devices.
Is your diabetes app a medical device?
It depends on what the app does, not on what it is called. FDA’s Policy for Device Software Functions and Mobile Medical Applications (September 2022) sorts software functions into three groups, and a single diabetes app can contain functions from more than one.
Not a device. Section 520(o) of the Federal Food, Drug, and Cosmetic Act excludes some software from the device definition, including functions for maintaining a healthy lifestyle and functions that only transfer, store, convert, or display device data without interpreting it. FDA’s guidance lists an app that lets a user record and log blood glucose readings as an example that is not a device.
A device, but low priority for FDA. FDA intends to exercise enforcement discretion for some functions that may meet the device definition but pose low risk. One example in the guidance is software that coaches patients with diabetes on weight, nutrition, exercise, or medication schedules through simple prompting.
A device under active FDA oversight. Functions that analyze or act on patient data are where oversight starts. The guidance names a software function that analyzes blood glucose readings and alerts the user when they fall outside a set range, and apps that control insulin delivery on a pump. FDA has also created dedicated classifications for interoperable diabetes components, such as the interoperable automated glycemic controller (21 CFR 862.1356), which calculates insulin doses from glucose and other inputs.
What changes when the app is a device. Development follows a quality management system under 21 CFR Part 820, software lifecycle processes under IEC 62304, risk management under ISO 14971, and usability engineering under IEC 62366-1. The premarket submission includes software documentation at a Basic or Enhanced level, per FDA’s Content of Premarket Submissions for Device Software Functions (June 2023). An app that connects to the internet is likely a “cyber device” under section 524B, which requires a plan for postmarket vulnerabilities and a software bill of materials.
Make this call before you write requirements. Adding a device function late, such as a glucose alert, can move the whole app into a higher documentation level. Read more in our guide to FDA regulation of mobile medical apps, or start with the basics of what counts as a mobile medical app.
Core features of a diabetes management app
With user needs defined, you can start building an MVP around the features that matter most. The table below lists the features most diabetes apps include, along with how each one tends to affect regulatory status.
| Feature | What it does | Regulatory note |
|---|---|---|
| Glucose logging | Records meter or CGM readings, manually or automatically | Logging alone is listed by FDA as not a device |
| Device integration | Pulls data from CGMs, pumps, meters, and wearables over Bluetooth | Display-only transfer may fall under the 520(o) data exclusion |
| Alerts and alarms | Warns of high or low glucose readings | Analyzing readings and alerting is a device function |
| Insulin and medication tracking | Logs doses and reminds users of schedules | Simple reminders may fall under enforcement discretion |
| Food and activity tracking | Logs meals, carbohydrates, and exercise | Usually lifestyle or wellness |
| Personalized dashboard | Shows trends, time in range, and goals | Depends on whether the app interprets data |
| Clinician sharing and EHR | Sends reports to the care team or EHR | Check HIPAA scope (business associate role) |
| Coaching and education | Gives tips and nudges | Coaching for diabetes is an enforcement discretion example |
Each feature’s regulatory status depends on its intended use and labeling, so confirm classification for your specific app.
A user-friendly interface
Diabetes management involves complex information and constant daily tasks, so the interface has to make both feel simple. Prioritize clarity, and cut cluttered layouts and anything users do not need.
Design for the conditions people actually use the app in. Users may have reduced vision or dexterity, or be in the middle of a hypoglycemic episode, so use large touch targets, high contrast, and as few steps as possible for critical tasks. Clear instructions, tooltips, and a short onboarding tutorial help new users get comfortable quickly.
Personalized dashboards and profiles
Diabetes care is individual, and the app should be too. Let users enter their medical history, treatment plan, dietary preferences, and activity level.
Present their data with clear visualizations that turn readings into actionable health metrics. Let users set personal goals and targets so they can track progress over time and stay motivated.
Integration with CGMs, pumps, and wearables
Interoperability is now a baseline expectation. Many users rely on several devices, so every integration you support adds value. Beyond CGMs and insulin pumps, consider activity, diet, menstrual cycle, and other health trackers that help centralize a user’s data.
FDA has created classifications for interoperable components: iCGM sensors (21 CFR 862.1355), ACE insulin pumps (21 CFR 880.5730), and interoperable automated glycemic controllers (21 CFR 862.1356). Apps built around these components connect through the manufacturer’s documented interfaces.
To make integration work for users:
- Support a wide range of wearable devices and sensors so users can choose what suits them.
- Use robust protocols to transmit and synchronize data securely.
- Offer customizable alerts based on user-defined thresholds across devices.
- Provide clear setup and pairing guidance to lower the barrier to adoption.
- Keep working with device makers and track sensor advances so the app stays compatible.
Real-time monitoring and feedback
Real-time feedback lets users track blood glucose, medication adherence, and lifestyle behaviors, and get guidance when it matters. Strong device integration is the foundation, since the feedback is only as good as the data behind it.
Real-time algorithms can generate personalized recommendations or alerts based on thresholds or patterns, and chatbots or virtual assistants can offer instant guidance. Keep in mind that glucose alerts that analyze readings are device functions; see the FDA section above.
Insights for users and healthcare providers
Analytics help users and providers make informed decisions and personalize care. Build algorithms that process large volumes of data efficiently, and design dashboards that make key insights easy to understand.
Machine learning and predictive analytics can turn data trends into personalized recommendations and alerts. Integrating with electronic health record systems lets providers review patient data inside the workflows they already use. A shared data platform gives providers a fuller picture and keeps patients engaged in their own care.
Data privacy and security
Diabetes apps collect sensitive health data, so security is central to earning user trust. Which privacy rules apply depends on who the app serves and where.
HIPAA applies when the app creates, receives, maintains, or transmits protected health information on behalf of a covered entity, such as a provider or health plan. Consumer apps outside HIPAA can still fall under the FTC Health Breach Notification Rule, which the FTC amended in 2024 to state that it applies to health apps. Apps used in the EU fall under GDPR. Our guide to HIPAA in MedTech development covers what a HIPAA-ready build involves.
Whatever rules apply, use strong encryption, access controls, and secure storage. Be transparent: publish a clear privacy policy and get explicit consent before collecting or sharing personal health information.
Security also covers the app itself. Threat-model the whole system, including the app, cloud services, and device connections. Encrypt data in transit and at rest, keep a software bill of materials, and plan how you will find and patch vulnerabilities after launch. If the app is a device that connects to the internet, FDA expects this work in the premarket submission. See our guide to medical device cybersecurity.
The diabetes app development process, step by step
- Define user needs. Interview people with diabetes, caregivers, and clinicians, and write needs as testable statements.
- Decide the regulatory path. List every app function and classify each one using FDA’s software guidance before you write requirements.
- Write requirements and assess risk. Turn needs into software requirements, and identify hazards such as a missed low-glucose alert under ISO 14971.
- Design the architecture. Plan device connections (Bluetooth to a CGM or pump), cloud services, EHR interfaces, and data flows, with security designed in from the start.
- Build an MVP in short iterations. Ship a narrow first version, using test-driven development so each feature has tests from day one.
- Apply usability engineering. Run formative evaluations with representative users, then a summative evaluation for device apps, per IEC 62366-1.
- Secure the app. Threat-model the system, encrypt data in transit and at rest, and keep a software bill of materials.
- Verify and validate. Confirm the software meets its requirements, and that the finished app meets user needs in real conditions.
- Submit, launch, and monitor. Prepare the premarket submission if the app is a device, then track complaints, vulnerabilities, and usage after launch.
Steps 6 to 9 are lighter for apps that are not devices, but the order still holds.
Test with real users
User testing shows how people actually behave with the app, what they prefer, and where they get stuck. Recruit a representative sample of your target users and assess usability, functionality, and the overall experience.
Watch users complete real tasks, such as logging a glucose reading or setting a medication reminder. Testing early catches usability problems and adoption barriers while they are still cheap to fix, and it confirms whether your design assumptions match how users work.
For apps that are devices, this testing follows IEC 62366-1 and FDA’s human factors guidance, ending in a summative evaluation. Either way, build feedback into each iteration and keep refining as user needs change. That ongoing loop also builds a working relationship with the people the app serves.
Frequently asked questions
Is a diabetes management app regulated by the FDA?
It depends on its functions. FDA lists apps that only log glucose readings as not devices, and treats simple diabetes coaching as low priority. Apps that analyze readings to alert users, or that control insulin delivery, are devices under FDA oversight. Classify each function before development starts.
What features should a diabetes management app have?
Most include glucose logging, CGM or meter integration, medication and insulin tracking, food and activity logs, a trend dashboard, and reports clinicians can read. Add alerts, coaching, and EHR sharing based on user research, and check how each feature affects regulatory status.
Can a diabetes app connect to a CGM?
Yes. Apps typically connect to CGMs over Bluetooth or through the manufacturer’s cloud interface. FDA has created classifications for interoperable components, including iCGM sensors, so device makers can design apps and controllers that work with sensors from other companies.
Does a diabetes app need to be HIPAA compliant?
Only in some cases. HIPAA applies when the app handles protected health information on behalf of a covered entity, such as a provider or health plan. A consumer app outside HIPAA may still fall under the FTC Health Breach Notification Rule, and EU users bring GDPR into scope.
What drives the cost of building a diabetes management app?
The biggest drivers are regulatory status, the number of device integrations, platform count (iOS, Android, web), and cloud and EHR connections. A device app adds design controls, risk management, usability testing, and submission documentation, which typically adds more effort than any single feature.
Build your diabetes app with Sequenex
A successful diabetes management app starts with its users, makes the regulatory call early, and keeps improving through testing. We have decades of experience in the diabetes and connected device industry, along with deep knowledge of medical software and the regulations that govern it.
If you are planning a diabetes management app, we can help you classify its functions, plan the architecture, and get to a tested MVP. See our biosensor and CGM software development services or connect with us to talk through your project.
